Catalyst Wire Dossier Catalyst Wire Dossier

Izamby

denosumab · Mabxience Research SL
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Izamby, covering 2025-12-02 to 2026-08-24. Get the full timeline:

Most recent: EMA Authorised: Izamby (denosumab) — Mabxience Research SL

See pricing